Product for relieving xerophthalmia and yellow spots on eye ground and preparation method thereof

Abstract

The invention discloses a product for relieving xerophthalmia and yellow spots on the eye ground and a preparation method thereof. The preparation method comprises following steps: evenly mixing and stirring sorbitol, magnesium stearate, critic acid, and edible essence to obtain an additive mixture; evenly mixing the additive mixture with water soluble haematococcus pluvialis astaxanthin, xanthophyll, vitamin A (or zeaxanthin), and vitamin C, stirring, and pressing the mixture to obtain the product. The production technology is simple. The product can be well absorbed and utilized by the humanbody, and can relieve xerophthalmia, yellow spots on the eye ground, and eye inflammation. The preparation process is simple. The cost is low. The preparation method is green, environmentally-friendly and pollution free. Large scale and massive production can be realized. The product does not have any side or toxic effect and is suitable for long-term administration.

Description

technical field [0001] The invention relates to a product for improving dry eye and fundus macula and a preparation method thereof, belonging to the field of health food and the like. Background technique [0002] With the change of people's lifestyle and the harm of bad habits, people's eye health is under unprecedented threat. The number of eye patients such as ocular inflammation, dry eye, and macula is increasing year by year, which will seriously affect people's normal life. . [0003] In recent years, the incidence of dry eye syndrome has remained high, and more and more attention has been paid to it in medicine. According to incomplete statistics, the incidence rate of dry eye syndrome among people aged 65-84 in China is about 20%. Dry eye syndrome refers to any The general term for various diseases caused by abnormal tear quality or quantity or abnormal dynamics, leading to decreased tear film stability, accompanied by ocular discomfort or ocular surface tissue lesi...

AI Technical Summary

Problems solved by technology

[0003] In recent years, the incidence of dry eye syndrome has remained high, and more and more attention has been paid to it in medicine. According to incomplete statistics, the incidence rate of dry eye syndrome among people aged 65-84 in China is about 20%. Dry eye syndrome refers to any The general term for various diseases caused by abnormal tear quality or quantity or abnormal dynamics, leading to decreased tear film stability, accompanied by ocular discomfort or ocular surface tissue lesions. Patients with dry eye will feel dry eyes, vision Gradually blurred, severe cases will cause blindness and night blindness, which seriously affects the normal life of patients, and the medicines currently used to treat dry eye have certain toxic and side effects, and patients will inevitably have adverse reactions after long-term use. Therefore, there is an urgent need for a drug that can improve , products for the treatment of dry eye syndrome